Tumor progression and oxidant-antioxidant status

Area of Science:

• Biochemistry
• Oncology
• Nutritional Science

Background:

• Prognostic factors in breast cancer correlate with plasma vitamin E and malondialdehyde levels.
• Understanding these associations in other cancer types is crucial for biomarker development.

Purpose of the Study:

• To investigate the association between lipid parameters (vitamin E, cholesterol, malondialdehyde) and cancer progression in various carcinomas.
• To determine if altered oxidant-antioxidant status is a general feature of cancer progression.

Main Methods:

• Plasma samples from 129 cancer patients were analyzed before therapy.
• Analyte concentrations (vitamin E, cholesterol, malondialdehyde) were measured.
• Patients were stratified by tumor size and presence of nodes/metastasis.

Main Results:

• Higher vitamin E/cholesterol ratios and lower cholesterol/malondialdehyde levels were observed in patients with larger tumors or metastasis.
• Multivariate analysis confirmed inverse association with low vitamin E/cholesterol ratio and direct association with low cholesterol/malondialdehyde and tumor progression.

Conclusions:

• Cancer progression is associated with significant alterations in lipid parameters and oxidant-antioxidant status across various cancer types.
• These findings suggest potential biomarkers for tumor growth and progression.